Patient costs for medication abortion: Results from a study of five clinical practices

Women's Health Issues

Volumn 16, Issue 1, 2006, Pages 4-13

  Van Bebber, Stephanie L ^a,b   Phillips, Kathryn A ^a,b   Weitz, Tracy A ^a   Gould, Heather ^a   Stewart, Felicia ^b,c  

^a Center Reproductive Health Research and Policy   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABORTION; ADULT; ARTICLE; CHILD CARE; CLINICAL PRACTICE; CONTROLLED STUDY; COST; FEMALE; HEALTH INSURANCE; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; MEDICATION ABORTION; PREGNANCY TEST; PRODUCTIVITY;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION APPLICANTS; ABORTION, INDUCED; ADOLESCENT; ADULT; CALIFORNIA; COSTS AND COST ANALYSIS; DATA COLLECTION; FEMALE; HEALTH EXPENDITURES; HEALTH FACILITIES; HUMANS;

EID: 32644462192     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.whi.2005.07.006     Document Type: Article

References (28)

1. Alan Guttmacher Institute (AGI). (2003). State facts about abortion. Available: http://www.agi-usa.org. Accessed August 27, 2004.
2. Alan Guttmacher Institute (AGI). (2004). State funding of abortion under Medicaid. State policies in brief, as of January 1, 2005. Available: http://www.guttmacher.org. Accessed January 14, 2005.
3. M.D. Creinin Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion Contraception 62 3 2000 117 124
4. M.D. Creinin, C. Potter, M. Holovanisin, L. Janczukiewicz, H.C. Pymar, J.L. Schwartz Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion American Journal of Obstetrics and Gynecology 188 2003 664 669
5. M.D. Creinin, E. Shore, S. Balasubramanian, B. Harwood The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion Contraception 71 2005 26 30
6. Danco Laboratories. (2004, November 15). Dear health care professional [Letter]. Available: http://www.earlyoptionpill. Retrieved October 5, 2005.
7. M.F. Drummond, B.J. O'Brien, G.L. Stoddart Methods for the economic evaluation of health care programmes 2nd ed 1997 Oxford University Press New York
8. L.B. Finer, S.K. Henshaw Abortion incidence and services in the United States in 2000 Perspectives on Sexual and Reproductive Health 35 1 2003 6 15
9. N. Folbre The invisible heart Economics and family values 2001 New Press New York
10. M. Gemperli, F.H. Stewart, K.A. Phillips, J. Sakowski, S.L. Van Bebber, L. Berghold Insurance coverage for mifepristone-induced abortion A case study of information contained in insurer policies Managed Care Interface 18 3 2005 26 30
11. S. Gibb, C. Donaldson, R. Henshaw Assessing strength of preference for abortion method using 'willingness to pay' A useful research technique for measuring values Journal of Advanced Nursing 27 1 1998 30 36
12. M. Gold, J. Siegel, L. Russell, M. Weinstein Cost-effectiveness in health and medicine 1996 Oxford University Press New York
13. D.A. Grimes Clinicians who provide abortions The thinning ranks Obstetrics and Gynecology 80 1992 719 723
14. A. Haddix S. Teutsch P. Corso Prevention effectiveness a guide to decision and economic evaluation 2003 Oxford University Press Oxford/New York
15. M. Harrington Meyer Care work Gender, class, and the welfare state 2000 Routledge New York
16. S.M. Harvey, L.J. Beckman, S.J. Satre Choice of and satisfaction with methods of medical and surgical abortion among U.S. clinic patients Family Planning Perspectives 33 5 2001 212 216
17. R.C. Henshaw, S.A. Naji, I.T. Russell, A.A. Templeton Comparison of medical abortion with surgical vacuum aspiration Women's preferences and acceptability of treatment British Medical Journal 307 6906 1993 714 717
18. S.K. Henshaw, L.B. Finer The accessibility of abortion services in the United States, 2001 Perspectives on Sexual and Reproductive Health 35 1 2003 16 24
19. S.K. Henshaw, L.S. Wallisch The Medicaid cutoff and abortion services for the poor Family Planning Perspectives 16 1984 171 172 177-180
20. C. Joffe, T.A. Weitz Normalizing the exceptional Incorporating the "abortion pill" into mainstream medicine Social Science and Medicine 56 2003 2353 2366
21. R.K. Jones, J.E. Darroch, S.K. Henshaw Patterns in the socioeconomic characteristics of women obtaining abortions in 2000-2001 Perspectives on Sexual and Reproductive Health 34 2002 226 235
22. A. Murthy, M.D. Creinin Pharmacoeconomics of medical abortion A review of cost in the United States, Europe and Asia Expert Opinion on Pharmacotherapy 4 2003 503 513
23. C. Rorbye, M. Norgaard, L. Nilas Medical versus surgical abortion Comparing satisfaction and potential confounders in a partly randomized study Human Reproduction 20 2005 834 838
24. F.H. Stewart, E.S. Wells, S.K. Flinn, T.A. Weitz Early medical abortion Issues for practice 2001 UCSF Center for Reproductive Health Research & Policy San Francisco
25. K.S. Virgo, T.R. Carr, A. Hile, J.M. Virgo, G.M. Sullivan, J.G. Kaikati Medical versus surgical abortion A survey of knowledge and attitudes among abortion clinic patients Women's Health Issues 9 1999 143 154
26. T.A. Weitz, A. Foster, C. Ellertson, D. Grossman, F.H. Stewart "Medical" and "surgical" abortion Rethinking the modifiers Contraception 69 2004 77 78
27. E. Wiebe, S. Dunn, E. Guilbert, F. Jacot, L. Lugtig Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol Obstetrics and Gynecology 99 2002 813 819
28. E.R. Wiebe, P. Janssen Time lost from work among women choosing medical or surgical abortions Womens Health Issues 10 2000 327 332